Table 6. Baseline characteristics of patients in 34 GBM samples from the Affiliated People's Hospital of Jiangsu University.
| Numbers of patients | Low risk | High risk | |
|---|---|---|---|
| Age | |||
| ≤60 year | 19 | 9(35%) | 10(53%) |
| >60 year | 15 | 4(27%) | 11(73%) |
| Gender | |||
| Male | 19 | 8(420%) | 11(58%) |
| Female | 15 | 5(33%) | 10(67%) |
| Karnofsky score | |||
| ≤70 score | 22 | 7(32%) | 15(68%) |
| ≥80 score | 12 | 6(50%) | 6(50%) |
| Tumorlocation | |||
| Fronto lobe or temporal lobe | 12 | 5(42%) | 7(58%) |
| Other lobe* | 22 | 8(36%) | 14(64%) |
| Recurrence | |||
| Yes | 14 | 2(14%) | 12(86%) |
| No | 20 | 11(55%) | 9(45%) |
| MGMT methylight | |||
| methylated | 18 | 7(39%) | 11(61%) |
| unmethylated | 16 | 6(38%) | 10(62%) |
| IDH1 mutant | |||
| mutated | 3 | 1(33%) | 2(67%) |
| unmutated | 31 | 12(39%) | 19(61%) |
| Smoking | |||
| Yes | 11 | 3(27%) | 8(73%) |
| No | 23 | 10(43%) | 13(57%) |
| Family history of cancer† | |||
| Yes | 18 | 4(22%) | 14(78%) |
| No | 16 | 9(56%) | 7(44%) |
*
Other lobe including insular lobe,parietal lobe,cerebellar,lateral ventricles,fourth ventricle, occipital lobe and multiple lobes